MRI of histologically confirmed mammary carcinoma: Clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma

Journal of Computer Assisted Tomography

Volumn 21, Issue 5, 1997, Pages 773-779

  Rieber, Andrea ^a   Merkle, Elmar ^a   Böhm, Wolfgang ^a   Brambs, Hans Jürgen ^a   Tomczak, Reinhard ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Breasts, neoplasms; Magnetic resonance imaging, techniques; Magnetic resonance mammography (MRM)

Indexed keywords

CONTRAST MEDIA; MAMMOGRAPHY; TUMORS;

BREAST NEOPLASM; DIAGNOSTIC METHODS; DIAGNOSTIC PROCEDURE; MAGNETIC RESONANCE IMAGING, TECHNIQUE; MAGNETIC RESONANCE MAMMOGRAPHY; MAMMARY CARCINOMA; MR MAMMOGRAPHY; MULTIFOCAL; T1-WEIGHTED; T2 WEIGHTED;

MAGNETIC RESONANCE IMAGING;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAMMOGRAPHY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

EID: 0031458605     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-199709000-00023     Document Type: Article

References (39)

1. Heywang SH, Hahn D, Schmidt H, et al. MR imaging of the breast using Gd-DTPA. J Comput Assist Tomogr 1986;10:199-204.
2. Kaiser WA, Zeitler E. MR-imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 1989;170:681-6.
3. Heywang-Köbrunner SH, Haustein J, Pohl C, et al. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine. Radiology 1994;191:639-46.
4. Gerhardt P. Recommendations of the Committee of Magnetic Resonance Tomography: quality standards for the MRI of the breast. Annual Report of the German Roentgen Ray Society 1995; 43:59-61.
5. Gilles R, Zafrani B, Guinebretiere JM, et al. Ductal carcinoma in situ: MR-imaging-histopathologic correlation. Radiology 1995; 196:415-9.
6. Tesoro-Tess JD, Amoruso A, Rovini D, et al. Microcalcifications in clinically normal breast: the value of high field, surface coil, Gd-DTPA-enhanced MRI. Eur Radiol 1995;5:417-22.
7. Heywang-Köbrunner SH. Contrast-enhanced magnetic resonance imaging of the breast. Invest Radiol 1994;29:94-104.
8. Kaiser WA. MR-Mammographie. Radiologe 1993;33:292-8.
9. Öllinger H, Heins S, Sander B, et al. Gd-DTPA enhanced MRI of the breast: the most sensitive method for detecting multicentric carcinomas in female breast? Eur Radiol 1993;3:223-6.
10. Kopans DB. Imaging analysis of breast lesions. In: Harris JR, Lippman ME, Morrow M, Hellman D, eds. Diseases of the breast. Philadelphia: Lippincott-Raven, 1996:71-84.
11. Whitney WS, Herfekens RJ, Silverman J, Ikeda D, Brumbaugh J, Jeffrey S. Gadolinium-enhanced spectral-spatial MR imaging for evaluation of breast carcinoma. Radiology 1993;189:136.
12. Flickinger FW, Allison JD, Sherry RM, Wright JC. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI. Magn Res Imag 1993;11:617-20.
13. Harms SE, Flamig DP, Evans WP, Harries SA, Brown S. MR imaging of the breast: current status and future potential. AJR 1994;163:10399-47.
14. Stack JP, Redmond OM, Codd MC, Dervan PA, Ennis JT. Breast disease: tissue characterisation with Gad-DTPA enhancement profiles. Radiology 1990;174:491-4.
15. Fischer U, Vosshenrich R, Probst A, Burchhardt H, Grabbe E. Preoperative MR mammography in patients with breast cancer -useful information or useless extravagance? Fortschr Roentgenstr 1994;161:300-6.
16. Gazet JM, Rainsbury RM, Ford HT. Survey of treatment of primary cancer in Great Britain. Br Med J 1985;290:1793-5.
17. Harries SA, Lawrence RN, Scrivener R. Regional variation in the surgical treatment of early breast cancer. Br J Surg 1993;80:809.
18. Baker LH. Breast Cancer Detection Project: five-year summary report. CA Cancer J Clin 1982;32:194-225.
19. Lagios MD, Richards VE, Rose MR, Yel E. Segmental mastectomy without radiotherapy: short-term follow-up. Cancer 1983;52: 2153-79.
20. Schwartz GF, Patesfesky AS, Feig SA, Shaber GS, Schwartz AB. Multicentricity of nonpalpable breast cancer. Cancer 1980;45: 2913-6.
21. Fowble BL, Solin L, Schultz D, Rubenstein I, Goodman RL. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys 1990;19:833-42.
22. Holland R, Veling S, Mravunac M, Hendricks IH. Histologic multifocality of Tis, T1-2 breast carcinomas: implications for clinical trials of breast conserving treatment. Cancer 1985;56:979-90.
23. Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989;320:822-8.
24. Freeman C, Belliveau N, Kim T, Boivin IF. Limited surgery with or without radiotherapy for early breast carcinoma. J Can Assoc Radiol 1981;32:125-8.
25. Montgomery A, Greening W, Levene A. Clinical study of recurrence rate and survival time of patients with carcinoma of the breast treated by biopsy excision without any other therapy. J R Soc Med 1978;71:339-42.
26. Smitt MC, Nowels KW, Zdeblick MJ, et al. The importance of lumpectomy surgical margin status in long term results of breast conservation. Cancer 1995;76:259-67.
27. Liljegren G, Holmberg L, Adami H-O, Westman G, Graffman S, Bergh I. Section resection with and without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. JNCI 1994;86:717-22.
28. Ernst R, Weber A, von Liebe S, Friemann J. Wert der Sonographie in der präoperativen Diagnostik des multizentrischen/multifokalen Mammakarzinoms. In: Hansmann M, ed. Ultraschalldiagnostik 86. Berlin: Springer, 1986:463.
29. Fisher E, Gregorio R, Redmond C, Vellios F, Sommers S, Fisher B. Pathologic findings from the national surgical adjuvant breast project (protocol No. 4): observations concerning the multicentricity of mammary cancer. Cancer 1975;35:247-54.
30. Blichert-Toft M, Rose C, Anderson J, et al. Danish randomized trial comparing breast conserving therapy with mastectomy: six years of life-table analysis. JNCI Monogr 1992;11:19-25.
31. Veronesi U, Luini A, Del Vecchio M, et al. Radiotherapy after breast conserving surgery in women with localized cancer of the breast. N Engl J Med 1993;328:1587-91.
32. Kurtz J, Amalric R, Brandone H, et al. Local recurrence after breast-conserving surgery and radiotherapy: frequency, time course, and prognosis. Cancer 1989;63:1912-7.
33. Lichter A, Lippman M, Danforth D, et al. Mastectomy versus breast conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. J Clin Oncol 1992;10:976-83.
34. Van Dongen J, Bartelink H, Fentiment IS, et al. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancers: EORTC 10801 trial, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 1992;28A:801-5.
35. Robbins GF, Berg JW. Bilateral primary breast cancer: a prospective clinicopathological study. Cancer 1964;17:1501-27.
36. Chaudary MA, Millis RR, Hoskins EOL, et al. Bilateral primary cancer: a prospective study of disease incidence. Br J Surg 1984; 71:711-4.
37. King R, Terz JJ, Lawrence W. Experience with opposite breast biopsy in patients with operable breast cancer. Cancer 1976;37: 43-5.
38. Ronay G, Tulusan AH, Willgeroth F, Reitzenstein M, Adam R, Frobenius W. The role of mammography in the diagnosis of simultaneous secondary carcinoma of the contralateral breast. Geburtsh Frauenheilk 1988;48:579-83.
39. Senofsky GM, Wanebo HJ, Wilhelm MC, et al. Has monitoring of the contralateral breast improved the prognosis in patients treated for primary cancer? Cancer 1986;57:597-602.